Needham Investment Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.6M | Hold |
53,041
| – | – | 0.23% | 100 |
|
|
2025
Q4 | $5.1M | Buy |
53,041
+2,500
| +5% | +$243K | 0.32% | 78 |
|
|
2025
Q3 | $4.81M | Buy |
50,541
+500
| +1% | +$46K | 0.34% | 79 |
|
|
2025
Q2 | $4.36M | Sell |
50,041
-1,000
| -2% | -$84.8K | 0.35% | 72 |
|
|
2025
Q1 | $4.59M | Hold |
51,041
| – | – | 0.43% | 68 |
|
|
2024
Q4 | $4.08M | Hold |
51,041
| – | – | 0.31% | 86 |
|
|
2024
Q3 | $4.6M | Hold |
51,041
| – | – | 0.35% | 80 |
|
|
2024
Q2 | $4.02M | Hold |
51,041
| – | – | 0.33% | 85 |
|
|
2024
Q1 | $4.45M | Hold |
51,041
| – | – | 0.41% | 67 |
|
|
2023
Q4 | $4.2M | Hold |
51,041
| – | – | 0.53% | 57 |
|
|
2023
Q3 | $4M | Hold |
51,041
| – | – | 0.68% | 44 |
|
|
2023
Q2 | $4.5M | Hold |
51,041
| – | – | 0.74% | 37 |
|
|
2023
Q1 | $4.11M | Hold |
51,041
| – | – | 0.71% | 45 |
|
|
2022
Q4 | $3.97M | Hold |
51,041
| – | – | 0.72% | 46 |
|
|
2022
Q3 | $4.12M | Hold |
51,041
| – | – | 0.81% | 43 |
|
|
2022
Q2 | $4.58M | Hold |
51,041
| – | – | 0.86% | 41 |
|
|
2022
Q1 | $5.66M | Hold |
51,041
| – | – | 0.82% | 44 |
|
|
2021
Q4 | $5.28M | Hold |
51,041
| – | – | 0.66% | 54 |
|
|
2021
Q3 | $6.4M | Sell |
51,041
-865
| -2% | -$112K | 0.85% | 42 |
|
|
2021
Q2 | $6.44M | Hold |
51,906
| – | – | 0.94% | 37 |
|
|
2021
Q1 | $6.13M | Hold |
51,906
| – | – | 0.84% | 48 |
|
|
2020
Q4 | $6.08M | Hold |
51,906
| – | – | 1.02% | 38 |
|
|
2020
Q3 | $5.39M | Sell |
51,906
-2,000
| -4% | -$201K | 1.08% | 34 |
|
|
2020
Q2 | $4.94M | Hold |
53,906
| – | – | 1.06% | 37 |
|
|
2020
Q1 | $4.86M | Hold |
53,906
| – | – | 1.38% | 23 |
|
|
2019
Q4 | $6.12M | Hold |
53,906
| – | – | 1.67% | 22 |
|
|
2019
Q3 | $5.86M | Hold |
53,906
| – | – | 1.88% | 21 |
|
|
2019
Q2 | $5.25M | Hold |
53,906
| – | – | 1.73% | 21 |
|
|
2019
Q1 | $4.91M | Hold |
53,906
| – | – | 1.67% | 22 |
|
|
2018
Q4 | $4.9M | Sell |
53,906
-500
| -0.9% | -$46.7K | 1.84% | 22 |
|
|
2018
Q3 | $5.35M | Hold |
54,406
| – | – | 1.61% | 24 |
|
|
2018
Q2 | $4.66M | Sell |
54,406
-3,790
| -7% | -$317K | 1.31% | 28 |
|
|
2018
Q1 | $4.67M | Hold |
58,196
| – | – | 1.33% | 25 |
|
|
2017
Q4 | $4.7M | Hold |
58,196
| – | – | 1.25% | 27 |
|
|
2017
Q3 | $4.53M | Hold |
58,196
| – | – | 1.15% | 30 |
|
|
2017
Q2 | $5.16M | Hold |
58,196
| – | – | 1.37% | 26 |
|
|
2017
Q1 | $4.69M | Hold |
58,196
| – | – | 1.21% | 26 |
|
|
2016
Q4 | $4.15M | Hold |
58,196
| – | – | 1.06% | 31 |
|
|
2016
Q3 | $5.03M | Hold |
58,196
| – | – | 1.33% | 25 |
|
|
2016
Q2 | $5.05M | Hold |
58,196
| – | – | 1.39% | 25 |
|
|
2016
Q1 | $4.37M | Hold |
58,196
| – | – | 1.14% | 28 |
|
|
2015
Q4 | $4.48M | Hold |
58,196
| – | – | 1.11% | 30 |
|
|
2015
Q3 | $3.9M | Hold |
58,196
| – | – | 0.98% | 32 |
|
|
2015
Q2 | $4.31M | Hold |
58,196
| – | – | 0.93% | 33 |
|
|
2015
Q1 | $4.54M | Buy |
+58,196
| New | +$4.41M | 0.97% | 32 |
|
Other funds holding MDT
VCM
VPM
Needham Investment Management's MDT Position: Q1 2026 in Review
Needham Investment Management held its Medtronic (MDT) position steady in Q1 2026 at 53,041 shares worth $4.6M. The position accounts for 0.23% of the portfolio, ranked #100.
Needham Investment Management first reported a position in MDT in Q1 2015 and has held it in 45 quarters since. The position peaked at $6.44M in Q2 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Needham Investment Management held 53,041 shares of Medtronic worth $4.6M as of Q1 2026.
- Needham Investment Management left its Medtronic share count unchanged in Q1 2026.
- Medtronic made up 0.23% of Needham Investment Management's portfolio in Q1 2026, its #100 holding.
- Needham Investment Management first reported a position in Medtronic in Q1 2015 and has held it in 45 quarters since.
- Needham Investment Management's Medtronic position peaked at $6.44M in Q2 2021.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Needham Investment Management's 13F filing for Q1 2026, filed 15 May 2026.